Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0148607116671942 | DOI Listing |
Arch Dermatol Res
June 2024
Division of Clinical Dermatology & Cutaneous Science, Department of Medicine, Halifax, Canada.
Secukinumab is a fully human IgG1 antibody that selectively binds to and neutralizes the proinflammatory cytokine interleukin-17A. Secukinumab is an effective and well-tolerated treatment for plaque psoriasis. There is a limited real-word evidence for dose optimisation of secukinumab based on clinical response.
View Article and Find Full Text PDFJ Am Acad Dermatol
September 2024
Department of Dermatology and Venereology, Saint Pierre-Brugmann and Queen Fabiola Children's University Hospitals, Universite Libre de Bruxelles, Brussels, Belgium.
Acta Diabetol
November 2023
Fundació DIABEM, Barcelona, Spain.
Aims: Since the Nobel Prize in Physiology or Medicine was awarded in 1923 to FG Banting and JJR Macleod, many voices have been raised against this decision. The bitterest protest was that of the Romanian scientist Nicolae C. Paulescu.
View Article and Find Full Text PDFJ Craniofac Surg
May 2023
Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Rochester, MN.
Background: Physicians from the Mediterranean civilization were profoundly instrumental in the early development and contemporary advancement of the craniomaxillofacial field. These feats are scarcely studied or acclaimed. In this editorial, the authors explore the contributions of these major Mediterranean pioneers.
View Article and Find Full Text PDFPsychoneuroendocrinology
January 2023
Daniel B. Fayerweather Professor of Political Economy and Sociology Emeritus, Department of Sociology, Bowdoin University, USA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!